Cargando…

Insulin-like growth factor-1 during renal replacement therapy in patients with multiple organ failure

Detalles Bibliográficos
Autores principales:	Yakovleva, I, Timokhov, V, Lialikova, G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2005
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4098504/ http://dx.doi.org/10.1186/cc3417

Ejemplares similares

Cortisol elimination properties during intermitting hemofiltration in patients with acute renal failure
por: Timokhov, V, et al.
Publicado: (2005)

Kinetics of TNF-α during continuous hemodiafiltration in patients with sepsis
por: Iakovleva, I, et al.
Publicado: (2004)

Renal replacement therapy for acute renal failure in the intensive care unit is associated with a worse prognosis than renal replacement therapy for end-stage renal failure
por: Ostermann, M, et al.
Publicado: (2005)

Incidence and outcome of acute renal failure necessitating renal replacement therapy after trauma
por: Beitland, S, et al.
Publicado: (2009)

Efficiency of substitutive renal therapy in the complex intensive care of multiple organ failure in patients with polytrauma
por: Kravtsov, S, et al.
Publicado: (2013)

Protein losses in continuous renal replacement therapies
por: Rodigues, MG, et al.
Publicado: (2005)

Antimicrobial resistance in bloodstream infection does not affect outcome in intensive care unit patients with acute renal failure treated with renal replacement therapy
por: Hoste, E, et al.
Publicado: (2005)

Outcome in critically ill medical patients requiring renal replacement therapy for acute renal failure: comparison between patients with and without hematologic malignancies
por: Benoit, D, et al.
Publicado: (2004)

Amino acid adherence in continuous renal replacement therapies
por: Rodrigues, MG, et al.
Publicado: (2005)

Fluid balance and renal outcomes in patients requiring renal replacement therapy in the ICU
por: Silversides, JA, et al.
Publicado: (2013)

Influence of the number of nurses on survival in multiple system organ failure
por: Mikor, A, et al.
Publicado: (2008)

Long-term mortality of critically ill patients with acute renal failure requiring renal replacement therapy: a 5-year population-based cohort study
por: Christensen, S, et al.
Publicado: (2006)

Hypercalcemia during renal replacement therapy after liver transplantation
por: Matsumi, J, et al.
Publicado: (2011)

Continuous renal replacement therapy: are we getting the dose right?
por: Martin, S, et al.
Publicado: (2010)

Renal replacement therapy in very elderly critical care patients
por: Brown, K, et al.
Publicado: (2014)

Extracorporeal renal replacement therapy in patients with heparin-induced thrombocytopenia
por: Bekers-Anchipolovskis, M, et al.
Publicado: (2009)

Stability of citrate and calcium dosing in citrate renal replacement therapy
por: Sadaat, F, et al.
Publicado: (2015)

Tedizolid clearance by in vitro continuous renal replacement therapy model
por: Lewis, SJ, et al.
Publicado: (2015)

Micronutrient loss in renal replacement therapy for acute kidney injury
por: Oh, W, et al.
Publicado: (2015)

An audit of antibiotic dosing according to renal function or renal replacement therapy in critical care
por: Donnelly, KD, et al.
Publicado: (2011)

Determinants of renal recovery and mortality inpatients undergoing continuous renal replacement therapy in the ICU
por: Gleeson, PJ, et al.
Publicado: (2015)

Intravenous immunoglobulin reduces the ischemia/reperfusion-induced renal injury by increasing insulin-like growth factor-I production in mice
por: Harada, N, et al.
Publicado: (2008)

Recovery of renal function after acute kidney injury requiring continuous renal replacement therapy
por: Jung, HY, et al.
Publicado: (2014)

Long-term renal and survival outcomes in acute kidney injury patients receiving renal replacement therapy in intensive care
por: Elsayed, I, et al.
Publicado: (2015)

Protein losses and nitrogen balance during continuous renal replacement therapy
por: Hayami, H, et al.
Publicado: (2011)

Renal replacement therapy and bloodstream infections in cardiovascular intensive care patients
por: Strabelli, TMV, et al.
Publicado: (2006)

Metabolic disturbances encountered during pediatric continuous renal replacement therapy
por: Soysal, D, et al.
Publicado: (2006)

Outcome of patients treated with renal replacement therapy for acute kidney injury
por: Desegher, A, et al.
Publicado: (2006)

Influence of veno-venous renal replacement therapy on transpulmonary thermodilution measurements
por: Sakka, S, et al.
Publicado: (2006)

Removal of inflammatory mediators by continuous renal replacement therapy in severe sepsis
por: Tomas, E, et al.
Publicado: (2009)

Fluid accumulation post cardiac surgery and risk for renal replacement therapy
por: Moore, EM, et al.
Publicado: (2014)

Clinical evaluation of endotoxin hemoadsorption therapy (PMX-DHP) for hypercytokinemia caused by septic multiple organ failure
por: Ikeda, T, et al.
Publicado: (2004)

Previous renal support is a predictor for chronic renal replacement therapy after orthotopic liver transplantation
por: Andreoli, MCC, et al.
Publicado: (2011)

Use of 2-hourly creatinine clearance to inform cessation of renal replacement therapy
por: Solymos, O, et al.
Publicado: (2011)

Pharmacokinetics of meropenem during continuous renal replacement therapy in critically ill patients
por: Solé Violan, J, et al.
Publicado: (2014)

Infection in ICU patients with acute kidney injury treated with renal replacement therapy
por: Reynvoet, E, et al.
Publicado: (2006)

Safety of drotrecogin alfa (activated) treatment in patients with severe sepsis on renal replacement therapy without additional anticoagulation
por: Mirea, L, et al.
Publicado: (2011)

Expanded Multiple Organ Dysfunction score: is it better than the Sequential Organ Failure Syndrome score?
por: Haddad, Z, et al.
Publicado: (2006)

Insulin-like growth factor signalling in oestrogen nonresponsive breast cancer cells
por: de Blaquiere, GE, et al.
Publicado: (2006)

Glutamine serum, adherence and losses in continuous renal replacement therapies in critically ill patients
por: Rodigues, MG, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_5o7usacmk5sds6glurv3k27s2l